Congress moves to put protections on painkiller

“Too many of our loved ones are dying every day from prescription drug overdoses and are abusing hydrocodone painkillers for non-medical purposes,” Buchanan said in a press release.

In 2010, two million people reported using prescription painkillers non-medically for the first time within the previous year, according to a report by the Centers for Disease Control and Prevention (CDC).

In the upper chamber, Sens. Joe ManchinJoseph (Joe) ManchinOvernight Energy — Sponsored by the National Biodiesel Board — Trump moves to ease Obama water rule | EPA document contradicts agency over water rule data| Manchin to be top Dem on Senate Energy panel Coal supporter Manchin named top Dem on Senate Energy Committee Schumer to Trump: Future infrastructure bill must combat climate change MORE (D-W.Va.) and Mark KirkMark Steven KirkDems vow swift action on gun reform next year This week: Trump heads to Capitol Hill Trump attending Senate GOP lunch Tuesday MORE (R-Ill.) are sponsoring a companion bill.

"As responsible leaders, we cannot stand by and let prescription drug abuse become one of the fastest growing epidemics in our country," Kirk said.

“Prescription drug abuse threatens families in Massachusetts and across the country with no regard for income, education, or political party. Congress needs to step up and take action to help fight the epidemic of prescription drug abuse sweeping the country,” Markey added.


There has been a 300 percent increase in painkiller prescriptions in the United States, the CDC reported. In 2008, nearly 15,000 people died from a painkiller overdose – more than cocaine and heroin combined.

Last month, Buchanan and Markey signed a letter with five senators, asking FDA Commissioner Margaret Hamburg to reschedule hydrocodone drugs, doubling down on an expert panel at the FDA that voted 19-10 in January for the change.

The number of chronic abusers of hydrocodone in the U.S. has increased to more than 24 million since 1999, when Congress sent a petition to the agency on the issue, lawmakers said.

A March reply from the FDA indicated that because the schedule change must be initiated by legislation or a rulemaking effort by the Drug Enforcement Agency (DEA), lawmakers shouldn’t expect quick progress.

But Buchanan and Markey are on an aggressive campaign to gain support for the bill, which was originally introduced in the last Congress, but has since been slimmed down to only focus on hydrocodone.

In a letter sent out to their colleagues, the congressmen highlight advice from Dr. Andrew Kolodny, the president of Physicians for Responsible Opioid Prescribing.

“When you wonder why your dentist gives you 40 hydrocodone for a toothache … that's because they're under the impression that it's not addictive as Percocet,” he said. “That's completely false."

Kolodny has been on the Hill several times to testify on the topic and endorsed the legislation.

“This legislation will correct an error made over 40 years ago, when the Controlled Substances Act incorrectly classified hydrocodone combination products,” he said in a statement.